Complete Story
 

01/19/2010

Robert A. Chapman, M.D.

Dr. Robert Chapman is beginning his third term on the MSHO Board of Directors. Bob's position as Director of the Josephine Ford Cancer Center at Henry Ford, his involvement in the Michigan Cancer Consortium and other state and national organizations, his participation in major clinical trials and his dedication to Michigan's medically underserved patients provides valued expertise and perspective to the work of the Society.

Following graduation from Haverford College in Pennsylvania, Dr. Chapman obtained his medical degree from Cornell Medical School and completed his internal medicine residency at Henry Ford Hospital. His medical oncology training was at Memorial Sloan Kettering. Since 1981, his career at Henry Ford has evolved from staff physician to Hematology/Oncology Division Head to Director of the Josephine Ford Cancer Center. During his career at Henry Ford he has served on numerous hospital governance groups and he is currently Chairman of the Cancer Coordinating Committee and a member of the Josephine Ford Cancer Center Executive Group an the Department of Medicine Executive Committee.

As a clinical researcher, he is well-known for his lung cancer research and involvement in major national trials. Dr. Chapman has served on the National Cancer Institute Scientific Review Group, American Cancer Society, and the governing board of the Southwest Oncology Group. Bob has been recognized as a Top Doc in Hour Detroit magazine for several years and has been listed as one of America's Top Doctors for Cancer.

Bob has dedicated much of his time to professional education. He has been program chair of numerous CME presentations. His cv lists pages of publications and lectures at many local and national conferences. On October 1st Dr. Chapman has agreed to share his expertise with our oncology fellows, physician extenders and other MSHO members by presenting a review of Thoracic Malignancies as part of our annual State of the Art Dinner Series.

Access to cancer early detection, screening and treatment is a passion for Dr. Chapman. In 2006, he worked to secure a competitive Medicare grant to study disparities in cancer care in the African American population. Henry Ford Health System was awarded $5.4 million in national funding to determine if working to overcome barriers such as transportation, assistance with co-pays and facilitating cancer screenings, diagnosis and treatment could reduce disparities in cancer death rates among African-Americans. Since the project began, more than 3,500 African American participants have been recruited for the project and results have been significant including more than doubling the rates for breast and prostate cancer screenings.